Cystic fibrosis gene therapy - CFTR-cationic liposome complex
Alternative Names: CFTR gene-cationic liposome complexLatest Information Update: 07 Jan 2004
At a glance
- Originator Nonindustrial sources
- Class Gene therapies
- Mechanism of Action Cystic fibrosis transmembrane conductance regulator stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cystic fibrosis
Most Recent Events
- 07 Jan 2004 No development reported - Preclinical for Cystic fibrosis in USA (unspecified route)
- 19 Jul 2001 No-Development-Reported for Cystic fibrosis in United Kingdom (Intranasal)
- 19 Jul 2001 Preclinical development for Cystic fibrosis in USA (Unknown route)